HOVERINK BIOTECHNOLOGIES, INC. RESTRICTED STOCK GRANT AGREEMENT
HOVERINK BIOTECHNOLOGIES, INC.
RESTRICTED STOCK GRANT AGREEMENT
___________, 2017
WHEREAS, the Board of Hoverink Biotechnologies, Inc., a Delaware Corporation (the “Company”), has determined that the grant of Restricted shares of the Company’s Common Stock to Xxxxxx Xxx Xxxxxx , (the “Chief Executive Officer”) in recognition and appreciation of services previously performed by the Chief Executive Officer on behalf of the Company is an effective means to align management interest with stockholder interests;
WHEREAS, the continued participation of the Chief Executive Officer is considered by the Company to be valuable to the Company’s growth; and:
WHEREAS, the Company is willing to grant, and the Chief Executive Officer named below is willing to accept, Restricted shares of the Company’s authorized Common Stock, par value $0.0001 per share, according to the terms and conditions contained herein.
1.
NOTICE OF GRANTS OF STOCK
Name: Xxxxxx Xxx Xxxxxx , Chief Executive Officer
You have been granted shares of Common Stock of the Company, on the following dates and in the following amounts, subject to the terms and conditions of this Agreement:
2.
AGREEMENT
a)
Issuance of Shares . By signing below, Xxxxxx Xxx Xxxxxx hereby accepts from the Company, and in recognition and appreciation of but not as compensation for past services to the Company, the Company hereby issues to the Chief Executive Officer an aggregate of 6,800,000 which shall vest immediately for a total amount of 6,800,000 shares of Common Stock (the “Shares”), on the schedule set forth below. The Company will, promptly after execution of this Agreement, issue a certificate representing the Share registered in the name of the Chief Executive Officer or as directed by the Chief Executive Officer. Alternatively, upon request by the Chief Executive Officer, the Company will work with its transfer agent to have the Shares delivered electronically to a brokerage account of the Chief Executive Officer. In return, the Chief Executive Officer will deliver to the Company an executed counterpart of this Agreement.
b)
Vesting . 6,800,000 Shares shall be fully vested upon issuance to the Chief Executive Officer.
Dates of Grant Total
Number of Shares of Stock
_______ , 2017
6,800,000 Par Value $ .0001
TOTAL 6,800,000 Shares of Common Stock
3.
Definitions . As used herein, the following definitions will apply:
a)
“Board” means the Board of the Company or any committee of an individual or individuals that has been designated by the Board to administer this Agreement.
b)
“Common Stock” means the Common Stock of the Company, par value $0.0001 per share.
c)
“Securities Act” means the Securities Act of 1933, as amended.
4.
Withholding of Taxes . By signing below, Xxxxxx Xxx Xxxxxx , acknowledges that the issuance of the Shares on the schedule set forth above may constitute compensation or have other taxable consequences to the Vice President, and that grants will be treated as supplemental wages and be added to the Vice President’s W-2 Form. The Company will be responsible for payment of its portion of any applicable Social Security and Medicare taxes relating to the Shares, and the Chief Executive Officer will be responsible for payment of his or her portion. The Chief Executive Officer acknowledges and agrees that the Shares are subject to appropriate income tax withholding, and that the Chief Executive Officer shall be responsible for any liability for any federal, state or local income taxes required by law to be withheld with respect to such Shares (the “Withholding Taxes”).
5.
Tax Consequences . In addition to the acknowledgement above in Section 4, the Chief Executive Officer represents and warrants that he or she has reviewed with his or her own tax and financial advisors the federal, state, local, and foreign tax consequences of this investment and the transactions contemplated by this Agreement (including, without limitation, the withholding provisions of Section 4 of this Agreement). The Chief Executive Officer is relying solely on such tax and financial advisors and not any statements or representations of the Company or any agent of or legal, tax, or financial advisor to the Company. The Chief Executive Officer understands that he or she (and not the Company) shall be responsible for the Chief Executive Officer’s own tax liability that may arise as a result of this investment or the transactions contemplated by this Agreement.
6.
Additional Actions . The parties shall execute such further instruments and take such further action as may reasonably be necessary to carry out the intent of this Agreement.
7.
Rights as Shareholder . The Chief Executive Officer shall be the record owner of the Shares until or unless such shares are sold or transferred, and as record owner shall be entitled to all rights of a common stockholder of the Company, including, without limitation, voting rights with respect to the Shares, and the Chief Executive Officer shall receive, if and when paid, any dividends on all of the Shares granted hereunder as to which the Chief Executive Officer is the record holder on the applicable record date.
8.
General Provisions .
a)
This Agreement will be governed by the internal substantive laws, of Delaware. This Agreement represents the entire agreement between the parties with respect to the issuance of the Shares to the Chief Executive Officer.
b)
Any notice, demand or request required or permitted to be given by either the Company or the Chief Executive Officer pursuant to the terms of this Agreement will be in writing and will be deemed given when delivered personally or deposited in the U.S. mail, First Class with postage prepaid, and addressed to the parties at the addresses of the parties set forth at the end of this Agreement or such other address as a party may request by notifying the other in writing.
c)
The rights of the Company under this Agreement will be transferable to any one or more persons or entities, and all covenants and agreements hereunder will inure to the benefit of, and be enforceable by the Company’s successors and assigns.
d)
Either party’s failure to enforce any provision of this Agreement will not in any way be construed as a waiver of any such provision, nor prevent that party from thereafter enforcing any other provision of this Agreement. The rights granted both parties hereunder are cumulative and will not constitute a waiver of either party’s right to assert any other legal remedy available to it.
e)
The Chief Executive Officer agrees upon request to execute any further documents or instruments necessary or desirable to carry out the purposes or intent of this Agreement.
f)
THE CHIEF EXECUTIVE OFFICER ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREUNDER DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS AN CHIEF EXECUTIVE OFFICER FOR ANY PERIOD OR AT ALL, AND SHALL NOT INTERFERE WITH CHIEF EXECUTIVE OFFICER ’S RIGHT OR THE COMPANY’S RIGHT TO TERMINATE CHIEF EXECUTIVE OFFICER’S EMPLOYMENT WITH THE COMPANY AT ANY TIME, WITH OR WITHOUT CAUSE.
9.
Entire Agreement . By the Chief Executive Officer’s signature below, the Chief Executive Officer represents that he or she is familiar with the terms and provisions of this Agreement and hereby accepts it subject to all of the terms and provisions hereof. The Chief Executive Officer has reviewed this Agreement in its entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement, and fully understands all provisions of this Agreement. The Chief Executive Officer agrees to accept as binding, conclusive and final all decisions or interpretations of the Board upon any questions arising under this Agreement. The Chief Executive Officer further agrees to notify the Company upon any change in the residence indicated below.
IN WITNESS WHEREOF, this Stock Grant Agreement is deemed made as of the date first set forth above.
Chief Executive Officer
Dated The _______ Day Of ___________, Two Thousand _______
____________________________
Xxxxxx Xxx Xxxxxx , Chief Executive Officer
Hoverink Biotechnologies, Inc.
